Spanish National Research Council State

The Spanish National Research Council State Agency (CSIC) is the largest public research organisation in Spain, the fourth-largest public research institution in the European Union and the sixth in the world.

Its aim is “the promotion, coordination, development and dissemination of multidisciplinary scientific and technological research to contribute to the advancement of knowledge and economic, social and cultural development, as well as the training of personnel and advice to public and private entities in these fields”.

For this purpose, it has more than 11,000 employees, of which almost 4,000 are research staff, distributed in its 121 research institutes throughout the Spanish territory, except the Spanish School of History and Archaeology in Rome (Italy).

The CSIC leads the scientific production of Spain, with an annual average of 13,000 publications in internationally renowned scientific journals, with a very high percentage of publications in frontline journals: more than 70 % of the total published articles correspond to high impact articles (Q1). Regarding Knowledge Transfer, the CSIC is the top institution in Spain in patent generation, with 85 patent applications in 2021 .

Furthermore, the CSIC has extensive experience managing research infrastructures. It actively participates in different infrastructures included in the European Strategy Forum on Research Infrastructures 9 (ESFRI) and provides services to the entire scientific community through the management of several Spanish Singular Scientific and Technological Infrastructures (ICTS) such as the Calar Alto astronomical observatory, Doñana biological reserve-station, the European Synchrotron Radiation Facility, the Hespérides oceanographic research vessel, the Integrated Clean Room of Microelectronics, the Spanish Antarctic base Juan Carlos I, the Max Von Laue-Paul Langevin Institute and the Sarmiento de Gamboa oceanographic vessel.

The Institute of Physics of Cantabria (IFCA) is a Joint Centre with the combined effort of two institutions, Spanish National Research Council (CSIC) and University of Cantabria (UC) oriented to perform research on basic science: to understand the components of nature, from elementary particles (Particle Physics) to the largest structures of the Universe (Astronomy and Space Science) as well as the complex collective behaviour of matter (Statistical and Non-linear Physics).

The CSIC has maintained a steadily grow in all its aspects since its creation in 1995, reaching its current size of about 80 people, with about 29 staff researchers. It produces yearly more than 200 publications in the best journals in the respective fields and has nearly 20 active projects, obtaining external funding of about 2.0M/year, more than 80% of the total budget.​

Role of institution in the project

IFCA is involved in tasks 2.4 FAIR implementation support and 5.3 including directing subtask 5.3.5 Data FAIRification.

The group brings its experience in the project EOSC-Synergy including the  developments on automated FAIR data evaluators implementing the Research Data Alliance FAIR compliance principles: (https://github.com/EOSC-synergy/FAIR_eva).

We also have experience in personal data protection and in particular in de-identification of DICOM objects.

Dr. David Rodríguez González

Dr. David Rodríguez González is a researcher at IFCA's Advanced Computing and eScience group with research interests in data science, privacy protection and medical data, in particular medical imaging. He holds a PhD in Physics from the Univesity of Cantabria (Spain), and has previously worked at the Brain Research Imaging Centre, CCBS, The University of Edinburgh, and the National e-Science Centre/Data Intensive Research Group (also part of the University of Edinburgh). He has worked in several previous European projects like EDG, CrossGrid, int.eu.grid and EGEE, EOSC-Synergy and Cos4Cloud. He has also participated in national and regional projects both in Spain and Scotland (for instance SINAPSE). He has broad experience in data protection and information governance for medical imaging. He is currently co-coordinator of CSIC's Digital Science and Innovation Platform (PTI Ciencia Digital).

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.